Valiant Organics Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹304 Cr +93.6% YoYSee revenue, profit and what management said. You are viewing Q4 FY25.
VO

Valiant Organics Ltd

Q4 FY25Chemicals & Petrochemicals

Valiant Organics Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹204Cr
+15.3% YoY
+9.1% QoQ
Net profit
₹4Cr
Turned profitable YoY
−20% QoQ
Margin
10%
+11.2 pp YoY
+2 pp QoQ

Based on Valiant Organics Ltd's Q4 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹411
Market cap₹1.2K Cr
P/E23.7

The short version

Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10). Q4 FY25 Consolidated Financials (Page 12 & 9): - EBITDA: INR 203 Mn, up from INR (18) Mn in Q4 FY24 (YoY positive turnaround) - EBITDA Margin: 9.96%, improved from -1.02% in Q4 FY24 (YoY improvement of 1,098 bps) - PAT: INR 42 Mn, up from INR (202) Mn in Q4 FY24 (significant YoY recovery) - PAT Margin: 2.06%, versus -11.43% in Q4 FY24 (YoY positive turnaround) - EPS (Basic/Diluted): INR 1.52/share, compared to (3.81) in Q4 FY24 - Explicit Margin Outlook:

From Valiant Organics Ltd's Q4 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10).
  • Key chemistries sales volumes (MT) for Q4-FY25:
  • Chlorination: 379 MT (up from 360 MT in Q4-FY24)
  • Hydrogenation: 1,126 MT (up from 879 MT in Q4-FY24)
  • Ammonolysis: 458 MT (down from 513 MT in Q4-FY24) (Page 11)

2 more points from Valiant Organics Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

It only details existing manufacturing footprints with plant capacities and product types.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.

Valiant Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Valiant Organics Ltd Q4 FY25 results — key figures

Valiant Organics Ltd Q4 FY25 reported results vs Q4 FY24, ₹ crore
₹ CrQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue204177+15.3%187+9.1%
Operating profit (EBITDA)21-2—15+40%
Operating margin10%-1.2%+11.2 pp8%+2 pp
Profit before tax7-25—6+16.7%
Net profit (PAT)4-20—5-20%
EPS (₹)1.50-7.32—1.98-24.2%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Atul (Q4 FY25)

    Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…

  • Vidhi Specialty (Q4 FY25)

    109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…

  • Chemcon Speciality Chemicals (Q4 FY25)

    54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Clean Science (Q4 FY25)

    2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Valiant Organics Ltd Q4 FY25 results?

Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10). Q4 FY25 Consolidated Financials (Page 12 & 9): - EBITDA: INR 203 Mn, up from INR (18) Mn in Q4 FY24 (YoY positive turnaround) - EBITDA Margin: 9.96%, improved from -1.02% in Q4 FY24 (YoY improvement of 1,098 bps) - PAT: INR 42 Mn, up from INR (202) Mn in Q4 FY24 (significant YoY recovery) - PAT Margin: 2.06%, versus -11.43% in Q4 FY24 (YoY positive turnaround) - EPS (Basic/Diluted): INR 1.52/share, compared to (3.81) in Q4 FY24 - Explicit Margin Outlook:

What is Valiant Organics Ltd share price analysis?

Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.